Cargando…

Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis

BACKGROUND: Numerous studies show that the pretreatment neutrophil-to-lymphocyte ratio (NLR) is associated with the prognosis of patients with RCC. However, their findings are inconsistent, urging us to explore the prognostic value of NLR in RCC patients. METHODS: This study was pre-registered in PR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Yuan, Wu, Bo, Jia, Wei, Zhang, Zikuan, Chen, Qian, Wang, Dongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339475/ https://www.ncbi.nlm.nih.gov/pubmed/32631294 http://dx.doi.org/10.1186/s12894-020-00665-8

Ejemplares similares

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
por: Seng, Dongjie, et al.
Publicado: (2019)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2018)

Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma
por: Lee, Su-Min, et al.
Publicado: (2015)

Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis
por: Liu, Gang, et al.
Publicado: (2018)

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review
por: Wu, Jiayuan, et al.
Publicado: (2017)

Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis
por: Yin, Jun, et al.
Publicado: (2017)

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer
por: Shao, Bin, et al.
Publicado: (2022)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
por: Parosanu, Andreea Ioana, et al.
Publicado: (2023)

Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer
por: Kotha, Nikhil V, et al.
Publicado: (2021)

The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis
por: Lu, Yan, et al.
Publicado: (2020)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Impact of diabetes mellitus on the prognostic value of the neutrophil-lymphocyte ratio in renal cell carcinoma
por: Zheng, Yangqin, et al.
Publicado: (2019)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis
por: Li, Wenxia, et al.
Publicado: (2021)

Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
por: Leng, Jiali, et al.
Publicado: (2022)

Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis
por: Hu, Kaimin, et al.
Publicado: (2015)

The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis
por: Liu, Rongqiang, et al.
Publicado: (2020)

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2020)

The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms()
por: Eskiizmir, Gorkem, et al.
Publicado: (2018)

Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio for Renal Outcomes in Patients with Rapidly Progressive Glomerulonephritis
por: Mae, Yukari, et al.
Publicado: (2020)

Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
por: AWAJI, Kentaro, et al.
Publicado: (2021)

Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors
por: Na, Ning, et al.
Publicado: (2016)

Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2023)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis: Erratum
Publicado: (2018)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis: Erratum
Publicado: (2017)

Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer
por: Zhou, Danyang, et al.
Publicado: (2018)

Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma
por: Keskin, Suat, et al.
Publicado: (2014)

Prognostic value of combined pretreatment fibrinogen and neutrophil-lymphocyte ratio in digestive system cancers: a meta-analysis of 17 retrospective studies
por: Liu, Rongqiang, et al.
Publicado: (2021)

Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer
por: Chen, Jie, et al.
Publicado: (2015)

Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
por: Howard, Rachel, et al.
Publicado: (2019)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
por: Dalpiaz, Orietta, et al.
Publicado: (2017)

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
por: Shen, Jie, et al.
Publicado: (2019)

Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
por: Yin, Yongmei, et al.
Publicado: (2015)

Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
por: Wang, Siqian, et al.
Publicado: (2018)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma
por: Jiang, Yanming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j7otb7osat6cjdl8c983j4mvnv